Top Markets
Coin of the day
MabCure Inc. MabCure Inc.

MabCure Inc.

MBCI
Clasificación en acciones #41405
MabCure Inc., a development stage company, engages in developing and... MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Precio por acción
$0.0003
Última sincronización: 2026-08-11
Capitalización bursátil
$21.97K
Cambio (1 día)
0.00%
Cambio (1 año)
200.00%
País
US
Comercio MabCure Inc. (MBCI)

Categoría

Historial de dividendos de MabCure Inc. (MBCI)
MabCure Inc. (símbolo bursátil: MBCI) realizó un total de 0 pagos de dividendos.
La suma de todos los dividendos (ajustados por splits de acciones) es: 0.00
Rentabilidad por dividendo (TTM): 0
Pagos de dividendos de MabCure Inc. (MBCI) desde 2026 hasta 2026
Pagos anuales de dividendos
Año Dividendo (ajustado por splits de acciones) Cambiar
Not enough data for the provided dates.
Lista de todos los pagos de dividendos
Año Dividendo Cambiar
Not enough data for the provided dates.
Pagos de dividendos de empresas similares o competidoras